Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions

Bacteria, Anaerobic

  • Susceptibility
    Comparative In Vitro Activities of Torezolid (DA-7157) against Clinical Isolates of Aerobic and Anaerobic Bacteria in South Korea
    Jong Hwa Yum, Sung Hak Choi, Dongeun Yong, Yunsop Chong, Weon Bin Im, Dong-Kwon Rhee, Kyungwon Lee
  • Susceptibility
    Antimicrobial Susceptibility Patterns for Recent Clinical Isolates of Anaerobic Bacteria in South Korea
    Yangsoon Lee, Yongjung Park, Myung Sook Kim, Dongeun Yong, Seok Hoon Jeong, Kyungwon Lee, Yunsop Chong
  • Clinical Therapeutics
    Effect of Ceftaroline on Normal Human Intestinal Microflora
    Georgios Panagiotidis, Tobias Bäckström, Charlotte Asker-Hagelberg, Alena Jandourek, Andrej Weintraub, Carl Erik Nord
  • Susceptibility
    In Vitro Activity of Ceftaroline against 623 Diverse Strains of Anaerobic Bacteria
    D. M. Citron, K. L. Tyrrell, C. V. Merriam, E. J. C. Goldstein
  • Pharmacology
    Impact of Different Factors on the Probability of Clinical Response in Tigecycline-Treated Patients with Intra-Abdominal Infections
    S. M. Bhavnani, C. M. Rubino, P. G. Ambrose, T. J. Babinchak, J. M. Korth-Bradley, G. L. Drusano
  • Susceptibility
    In Vitro Activities of Telavancin and Six Comparator Agents against Anaerobic Bacterial Isolates
    Sydney M. Finegold, Mauricio Bolanos, Paula H. Sumannen, Denise R. Molitoris
  • Susceptibility
    Besifloxacin, a Novel Fluoroquinolone, Has Broad-Spectrum In Vitro Activity against Aerobic and Anaerobic Bacteria
    Wolfgang Haas, Chris M. Pillar, Gary E. Zurenko, Jacqueline C. Lee, Lynne S. Brunner, Timothy W. Morris
  • Susceptibility
    Antianaerobic Activity of Sulopenem Compared to Six Other Agents
    Lois M. Ednie, Peter C. Appelbaum
  • Susceptibility
    Study of the In Vitro Activities of Rifaximin and Comparator Agents against 536 Anaerobic Intestinal Bacteria from the Perspective of Potential Utility in Pathology Involving Bowel Flora
    S. M. Finegold, D. Molitoris, M.-L. Väisänen
  • Susceptibility
    In Vitro Activity of Tomopenem (CS-023/RO4908463) against Anaerobic Bacteria
    Kaori Tanaka, Hiroshige Mikamo, Kenichi Nakao, Taku Ichiishi, Takatsugu Goto, Yuka Yamagishi, Kunitomo Watanabe

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
Back to top

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596